Table 1.
Anthropometric and Metabolic Characteristics between Controls and Women with PCOS.
| Control | PCOS | p value | |
|---|---|---|---|
| Pre-Exercise | |||
| Age (yrs) | 33.9 ± 16.2 | 25.6 ± 3.1 | 0.20 |
| Weight (kg) | 75.3 ± 11.5 | 84.1 ± 16.6 | 0.24 |
| BMI (kg/m2) | 28.1 ± 5.0 | 32.1 ± 5.2 | 0.13 |
| % Fat | 31.3 ± 7.6 | 38.2 ± 5.2 | 0.20 |
| FM (kg) | 23.9 ± 8.6 | 32.8 ± 10.8 | 0.27 |
| FFM (kg) | 51.4 ± 7.5 | 51.4 ± 6.6 | 0.99 |
| VO2max (mL/FFM) | 23.7 ± 6.4 | 27.5 ± 3.7 | 0.27 |
| GDR (mg/min/EMBS) | 7.4 ± 3.9 | 5.1 ± 1.8 | 0.18 |
| HOMA-IR (AU) | 3.5 ± 3.8 | 3.6 ± 2.7 | 0.94 |
| SHGB (nmol/L) | 35.5 ± 18.3 | 30.9 ± 31.7 | 0.73 |
| Testosterone (ng/dL) | 36.9 ± 8.0 | 92.4 ± 41.2 | 0.006 |
| FAI (AU) | 1.2 ± 0.6 | 18.8 ± 14.2 | 0.02 |
| WBC (× 103/μL) | 6.7 ± 2.1 | 8.7 ± 1.4 | 0.04 |
| Neutrophils (× 103/μL) | 3.9 ± 1.7 | 4.2 ± 1.2 | 0.61 |
| hsCRP (mg/L) | 3.8 ± 5.2 | 4.6 ± 6.1 | 0.79 |
| Triglycerides (mg/dL) | 89.3 ± 52.6 | 95 ± 49.8 | 0.82 |
| Total Cholesterol (mg/dL) | 184.9 ± 27.6 | 165.5 ± 40.7 | 0.28 |
| HDL-C (mg/dL) | 63.5 ± 17.6 | 50.6 ± 11.7 | 0.10 |
| LDL-C (mg/dL) | 103.9 ± 18.9 | 95.9 ± 24.1 | 0.48 |
| Cholesterol/HDL | 3.1 ± 0.8 | 3.3 ± 0.4 | 0.48 |
| HDL/LDL | 0.6 ± 0.2 | 0.5 ± 0.1 | 0.26 |
| DHEA-S (μg/dL) | 130.9 ± 49.2 | 183.2 ± 80.3 | 0.13 |
| Total Adiponectin (μg/mL) | 6.7 ± 3.3 | 2.7 ± 1.3 | 0.003 |
Data is represented as mean ± SD. BMI, Body Mass Index; FM, Fat Mass; FFM, Fat Free Mass; GDR, Glucose Disposal Rate; EMBS, Estimated Mean Body Size; SHGB, Sex Hormone Binding Globulin; FAI, Free Androgen Index; WBC, White Blood Cell Count; hsCRP, high sensitivity C-Reactive Protein; HDL-C, High Density Lipoprotein-Cholesterol; LDL-C, Low Density Lipoprotein-Cholesterol; DHEA-S, Dehydroepiandrosterone-Sulfate